| CYHB2100265 | 吗替麦考酚酯片 | mycophenolate mofetil | Tablet | Chemical Drugs | Supplementary Application | 2021-03-02 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2021-03-01 | view |
| CYHB2100266 | 吗替麦考酚酯胶囊 | mycophenolate mofetil | Capsule | Chemical Drugs | Supplementary Application | 2021-02-25 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2021-02-24 | view |
| JYSB2100035 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2100033 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2100032 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| JYSB2100034 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.4) | Supplementary Application | 2021-01-27 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Certificate Issued | 2021-03-10 | view |
| CYHB2100020 | 注射用头孢曲松钠 | ceftriaxone sodium | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-01-06 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2021-01-06 | view |
| CYHB2100019 | 注射用头孢曲松钠 | ceftriaxone sodium | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-01-06 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2021-01-06 | view |
| CYHB2100018 | 注射用头孢曲松钠 | ceftriaxone sodium | Lyophilized | Chemical Drugs(原6) | Supplementary Application | 2021-01-06 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2021-01-06 | view |
| JYSB2000633 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSZ2000022 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSZ2000021 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSZ2000020 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSB2000634 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSB2000636 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSB2000635 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | Supplementary Application | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2021-01-05 | view |
| JYSZ2000023 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products | License Renew | 2020-12-18 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | In Review | 2020-12-16 | view |
| JYSF2000027 | 聚乙二醇干扰素α-2a注射液 | Peginterferon alfa 2a | Injection | Biological Products | Supplementary Application | 2020-12-09 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-12-25 | view |
| JYSF2000026 | 聚乙二醇干扰素α-2a注射液 | Peginterferon alfa 2a | Injection | Biological Products | Supplementary Application | 2020-12-09 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-12-25 | view |
| JYSB2000456 | 利妥昔单抗注射液 | rituximab | Injection | Biological Products(3.1) | Supplementary Application | 2020-09-10 | 上海罗氏制药有限公司 | Shanghai Roche Pharmaceutical Co Ltd | Filed | 2020-09-18 | view |
